Hansa Biopharma AB

HNSA NPV
Create an alert
Sell40.44 SEK
Buy40.66 SEK
2.88 SEK (7.61%)
Last updated today at 01:27 UTC
Trade

Key metrics

Open37.84 SEK
Previous close37.84 SEK
Market capSEK 3.85bn
P/E ratio-
Volume1,213,227
Dividend yield0.00%
EMS-

Company information

Hansa Biopharma AB, formerly Hansa Medical AB, is a Sweden-based biopharmaceutical company with focus on immunomodulatory enzymes for treatment and prevention of rare and severe autoimmune conditions and transplant ...

  • LocationSweden
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencySEK
  • Shares in issue103.79m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.